{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:14:50Z","timestamp":1789150490541,"version":"build-2803163510"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s40291-025-00775-9","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T09:54:21Z","timestamp":1743414861000},"page":"329-344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9449-7585","authenticated-orcid":false,"given":"Dikshat Gopal","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Monika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"4","key":"775_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11899-016-0326-1","volume":"11","author":"A Dias","year":"2016","unstructured":"Dias A, Kenderian SJ, Westin GF, Litzow MR. Novel therapeutic strategies in acute lymphoblastic leukemia. Curr Hematol Malig Rep. 2016;11(4):253\u201364.","journal-title":"Curr Hematol Malig Rep"},{"issue":"9","key":"775_CR2","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.humpath.2012.02.004","volume":"43","author":"Y Zhou","year":"2012","unstructured":"Zhou Y, You MJ, Young KH, Lin P, Lu G, Medeiros LJ, et al. Advances in the molecular pathobiology of B-lymphoblastic leukemia. Hum Pathol. 2012;43(9):1347\u201362.","journal-title":"Hum Pathol"},{"key":"775_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.pathol.4.110807.092227","volume":"4","author":"MA Teitell","year":"2009","unstructured":"Teitell MA, Pandolfi PP. Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol. 2009;4:175\u201398.","journal-title":"Annu Rev Pathol"},{"key":"775_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12703\/P6-59","volume":"6","author":"T Zuckerman","year":"2014","unstructured":"Zuckerman T, Rowe JM. Pathogenesis and prognostication in acute lymphoblastic leukemia. F1000Prime Rep. 2014;6:59.","journal-title":"F1000Prime Rep."},{"issue":"11","key":"775_CR5","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371(11):1005\u201315.","journal-title":"N Engl J Med"},{"issue":"1","key":"775_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1182\/asheducation-2014.1.174","volume":"2014","author":"CG Mullighan","year":"2014","unstructured":"Mullighan CG. The genomic landscape of acute lymphoblastic leukemia in children and young adults. Hematol Am Soc Hematol Educ Progr. 2014;2014(1):174\u201380.","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"issue":"9","key":"775_CR7","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1182\/blood-2004-07-2922","volume":"105","author":"M Mancini","year":"2005","unstructured":"Mancini M, Scappaticci D, Cimino G, Nanni M, Derme V, Elia L, et al. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. Blood. 2005;105(9):3434\u201341.","journal-title":"Blood"},{"issue":"8","key":"775_CR8","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","volume":"109","author":"AV Moorman","year":"2007","unstructured":"Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood. 2007;109(8):3189\u201397.","journal-title":"Blood"},{"issue":"2","key":"775_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","volume":"10","author":"ML Den Boer","year":"2009","unstructured":"Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009;10(2):125\u201334.","journal-title":"Lancet Oncol"},{"issue":"1","key":"775_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000338260","volume":"128","author":"P Bhatia","year":"2012","unstructured":"Bhatia P, Binota J, Varma N, Bansal D, Trehan A, Marwaha RK, et al. Incidence of common chimeric fusion transcripts in B-cell acute lymphoblastic leukemia: an Indian perspective. Acta Haematol. 2012;128(1):17\u20139.","journal-title":"Acta Haematol"},{"issue":"7","key":"775_CR11","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/leu.2012.23","volume":"26","author":"JQ Mi","year":"2012","unstructured":"Mi JQ, Wang X, Yao Y, Lu HJ, Jiang XX, Zhou JF, et al. Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases. Leukemia. 2012;26(7):1507\u201316.","journal-title":"Leukemia"},{"issue":"4","key":"775_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ajco.12400","volume":"11","author":"A Chopra","year":"2015","unstructured":"Chopra A, Soni S, Verma D, Kumar D, Dwivedi R, Vishwanathan A, et al. Prevalence of common fusion transcripts in acute lymphoblastic leukemia: a report of 304 cases. Asia Pac J Clin Oncol. 2015;11(4):293\u20138.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"23","key":"775_CR13","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1182\/blood.V126.23.2610.2610","volume":"126","author":"A Fasan","year":"2015","unstructured":"Fasan A, Wolfgang K, Nadarajah N, Weber S, Schindela S, Schlenther N, Schnittger S, Haferlach T, Haferlach C. Three steps to the diagnosis of adult Ph-like ALL. Blood. 2015;126(23):2610.","journal-title":"Blood"},{"issue":"7","key":"775_CR14","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.3324\/haematol.2014.117424","volume":"100","author":"JM Boer","year":"2015","unstructured":"Boer JM, Koenders JE, van der Holt B, Exalto C, Sanders MA, Cornelissen JJ, et al. Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates. Haematologica. 2015;100(7):e261\u20134.","journal-title":"Haematologica"},{"issue":"5","key":"775_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","volume":"129","author":"N Jain","year":"2017","unstructured":"Jain N, Roberts KG, Jabbour E, Patel K, Eterovic AK, Chen K, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 2017;129(5):572\u201381.","journal-title":"Blood"},{"issue":"1","key":"775_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3324\/haematol.2015.136366","volume":"102","author":"T Herold","year":"2017","unstructured":"Herold T, Schneider S, Metzeler KH, Neumann M, Hartmann L, Roberts KG, et al. Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis. Haematologica. 2017;102(1):130\u20138.","journal-title":"Haematologica"},{"issue":"12","key":"775_CR17","doi-asserted-by":"publisher","first-page":"e490","DOI":"10.3324\/haematol.2016.162925","volume":"102","author":"SL Heatley","year":"2017","unstructured":"Heatley SL, Sadras T, Kok CH, Nievergall E, Quek K, Dang P, et al. High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment. Haematologica. 2017;102(12):e490\u20133.","journal-title":"Haematologica"},{"issue":"25","key":"775_CR18","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1182\/blood-2016-12-758979","volume":"129","author":"SC Reshmi","year":"2017","unstructured":"Reshmi SC, Harvey RC, Roberts KG, Stonerock E, Smith A, Jenkins H, et al. Targetable kinase gene fusions in high-risk B-ALL: a study from the Children\u2019s Oncology Group. Blood. 2017;129(25):3352\u201361.","journal-title":"Blood"},{"issue":"4","key":"775_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","volume":"35","author":"KG Roberts","year":"2017","unstructured":"Roberts KG, Gu Z, Payne-Turner D, McCastlain K, Harvey RC, Chen IM, et al. High frequency and poor outcome of philadelphia chromosome-like acute lymphoblastic leukemia in adults. J Clin Oncol. 2017;35(4):394\u2013401.","journal-title":"J Clin Oncol"},{"key":"775_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.leukres.2018.08.009","volume":"72","author":"X Chen","year":"2018","unstructured":"Chen X, Wang F, Zhang Y, Wang M, Tian W, Teng W, et al. Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia. Leuk Res. 2018;72:99\u2013104.","journal-title":"Leuk Res"},{"issue":"8","key":"775_CR21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood-2018-04-841676","volume":"132","author":"KG Roberts","year":"2018","unstructured":"Roberts KG, Reshmi SC, Harvey RC, Chen IM, Patel K, Stonerock E, et al. Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children\u2019s Oncology Group. Blood. 2018;132(8):815\u201324.","journal-title":"Blood"},{"issue":"5","key":"775_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/bjh.15251","volume":"181","author":"S Chiaretti","year":"2018","unstructured":"Chiaretti S, Messina M, Grammatico S, Piciocchi A, Fedullo AL, Di Giacomo F, et al. Rapid identification of BCR\/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications. Br J Haematol. 2018;181(5):642\u201352.","journal-title":"Br J Haematol"},{"issue":"Supplement 1","key":"775_CR23","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1182\/blood-2018-99-115035","volume":"132","author":"G Tsaur","year":"2018","unstructured":"Tsaur G, Muhacheva T, Kovalev S, Druy A, Sibiryakov P, Olshanskaya Y, et al. Application of real-time PCR for the detection of BCR-ABL1-like group in pediatric acute lymphoblastic leukemia patients. Blood. 2018;132(Supplement 1):1376.","journal-title":"Blood"},{"issue":"1","key":"775_CR24","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2019.017","volume":"11","author":"N Gupta","year":"2019","unstructured":"Gupta N, Pawar R, Banerjee S, Brahma S, Rath A, Shewale S, et al. Spectrum and immunophenotypic profile of acute leukemia: a tertiary center flow cytometry experience. Mediterr J Hematol Infect Dis. 2019;11(1): e2019017.","journal-title":"Mediterr J Hematol Infect Dis."},{"issue":"4","key":"775_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5045\/br.2020.2020255","volume":"55","author":"JH Park","year":"2020","unstructured":"Park JH, Kang MG, Kim HR, Lee YE, Lee JH, Choi HJ, et al. Changing the frequency and spectra of chromosomal aberrations in Korean patients with acute leukemia in a tertiary care hospital. Blood Res. 2020;55(4):225\u201345.","journal-title":"Blood Res."},{"key":"775_CR26","doi-asserted-by":"crossref","unstructured":"Shen D, Liu L, Xu X, Song H, Zhang J, Xu W, Zhao F, Liang J, Liao C, Wang Y, Xia T, Wang C, Lou F, Cao S, Qin J, Tang Y. Spectrum and clinical characteristics of gene mutations in Chinese pediatric acute lymphoblastic leukemia. Res Square. 2021;1.","DOI":"10.21203\/rs.3.rs-651868\/v1"},{"issue":"6","key":"775_CR27","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3324\/haematol.2020.247973","volume":"106","author":"S Chiaretti","year":"2021","unstructured":"Chiaretti S, Messina M, Della Starza I, Piciocchi A, Cafforio L, Cavalli M, et al. Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. Haematologica. 2021;106(6):1559\u201368.","journal-title":"Haematologica"},{"issue":"6","key":"775_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41408-021-00504-5","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Wang F, Zhang Y, Ma X, Cao P, Yuan L, et al. Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center. Blood Cancer J. 2021;11(6):112.","journal-title":"Blood Cancer J"},{"issue":"2","key":"775_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4103\/0973-1482.147716","volume":"12","author":"M Sharma","year":"2016","unstructured":"Sharma M, Sachdeva MU, Varma N, Varma S, Marwaha RK. Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: a study from Northern India. J Cancer Res Ther. 2016;12(2):620\u20136.","journal-title":"J Cancer Res Ther"},{"issue":"21","key":"775_CR30","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1002\/cncr.34957","volume":"129","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Sharma P, Truica MI, Abdulkadir SA, Singh P, et al. Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B-lineage acute lymphoblastic leukemia: a report of 1021 patients from India. Cancer. 2023;129(21):3390\u2013404.","journal-title":"Cancer"},{"issue":"4","key":"775_CR31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1182\/bloodadvances.2021005634","volume":"6","author":"TH Tran","year":"2022","unstructured":"Tran TH, Langlois S, Meloche C, Caron M, Saint-Onge P, Rouette A, et al. Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001. Blood Adv. 2022;6(4):1329\u201341.","journal-title":"Blood Adv"},{"issue":"1","key":"775_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/tjh.galenos.2021.2021.0326","volume":"39","author":"DG Gupta","year":"2022","unstructured":"Gupta DG, Varma N, Naseem S, Sachdeva MUS, Bose P, Binota J, et al. Characterization of immunophenotypic aberrancies with respect to common fusion transcripts in B-cell precursor acute lymphoblastic leukemia: a report of 986 Indian patients. Turk J Haematol. 2022;39(1):1\u201312.","journal-title":"Turk J Haematol"},{"key":"775_CR33","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1016\/S2152-2650(23)00938-2","volume":"23","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Truica M, Tanwar PS, Abdulkadir SA, Siddiqui MR, et al. ALL-205 deconvoluting and characterizing the newly incorporated genetic subtypes and treatment outcomes of acute lymphoblastic leukemia: a report of 1,021 Indian patients 5-year study. Clin Lymphoma Myeloma Leuk. 2023;23:S241.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"775_CR34","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1016\/S2152-2650(22)01178-8","volume":"22","author":"DG Gupta","year":"2022","unstructured":"Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Sreedharanunni S, et al. ALL-061 delineating the genomic and proteomic landscape of BCR-ABL1-like acute lymphoblastic leukemia subtype: bench-to-bedside translational research. Clin Lymphoma Myeloma Leuk. 2022;22:S191\u20132.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"775_CR35","doi-asserted-by":"publisher","first-page":"S268","DOI":"10.1016\/S2152-2650(21)01652-9","volume":"21","author":"DG Gupta","year":"2021","unstructured":"Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Binota J, et al. ALL-125: PHi-RACE: PGIMER in-house rapid and cost-effective classifier for the rapid detection of BCR-ABLI-like acute lymphoblastic leukemia in Indian patients. Clin Lymphoma Myeloma Leuk. 2021;21:S268\u20139.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"775_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2020-136890","volume":"136","author":"DG Gupta","year":"2020","unstructured":"Gupta DG, Varma N, Naseem S, Sachdeva MUS, Malhotra P, Sreedharanunni S, et al. Detection of BCR-ABL1-like subtype in adult acute lymphoblastic leukemia using Digital Ncounter Nanostring Technology. Blood. 2020;136:13\u20134.","journal-title":"Blood"},{"issue":"5","key":"775_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.82","volume":"8","author":"Z Huang","year":"2024","unstructured":"Huang Z, Zhang L, Gong X, Li J, Deng S, Cai Z, et al. An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome-like acute lymphoblastic leukemia. Hemasphere. 2024;8(5): e82.","journal-title":"Hemasphere."},{"issue":"1","key":"775_CR38","first-page":"35","volume":"45","author":"HP Dai","year":"2024","unstructured":"Dai HP, Shen HJ, Li Z, Cui W, Cui QY, Li MY, et al. Efficacy and safety of chimeric antigen receptor T-cell therapy followed by allogeneic hematopoietic stem cell transplantation in 21 patients with Ph-like acute lymphoblastic leukemia. Zhonghua Xue Ye Xue Za Zhi. 2024;45(1):35\u201340.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"775_CR39","doi-asserted-by":"crossref","unstructured":"Tran TH, Tasian SK. How I treat Philadelphia chromosome-like acute lymphoblastic leukemia in children, adolescents, and young adults. Blood. 2025;145(1):20\u201334.","DOI":"10.1182\/blood.2023023153"},{"issue":"1","key":"775_CR40","first-page":"78","volume":"32","author":"TD Li","year":"2024","unstructured":"Li TD, Hu SY, Zhai Z, Chen GH, Lu J, He HL, et al. Clinical analysis of Philadelphia chromosome-like acute lymphoblastic leukemia in children. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024;32(1):78\u201384.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"775_CR41","doi-asserted-by":"publisher","first-page":"1362081","DOI":"10.3389\/fmolb.2024.1362081","volume":"11","author":"JV Gil","year":"2024","unstructured":"Gil JV, Miralles A, de Las HS, Such E, Avetisyan G, Diaz-Gonzalez A, et al. Comprehensive detection of CRLF2 alterations in acute lymphoblastic leukemia: a rapid and accurate novel approach. Front Mol Biosci. 2024;11:1362081.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"775_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3904\/kjim.2023.407","volume":"39","author":"JH Yoon","year":"2024","unstructured":"Yoon JH, Lee S. Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of gene analysis and targeted immunotherapy. Korean J Intern Med. 2024;39(1):34\u201356.","journal-title":"Korean J Intern Med"},{"issue":"5","key":"775_CR43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/ejh.14164","volume":"112","author":"M Podgorica","year":"2024","unstructured":"Podgorica M, Drivet E, Viken JK, Richman A, Vestbostad J, Szodoray P, et al. Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis. Eur J Haematol. 2024;112(5):731\u201342.","journal-title":"Eur J Haematol"},{"key":"775_CR44","doi-asserted-by":"publisher","first-page":"1256054","DOI":"10.3389\/fonc.2023.1256054","volume":"13","author":"D Lin","year":"2023","unstructured":"Lin D, Yang K, Yu L, Huang L, Lai X, Wu L, et al. Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes. Front Oncol. 2023;13:1256054.","journal-title":"Front Oncol"},{"issue":"Pt 1","key":"775_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127596","volume":"254","author":"SMA Mohamed","year":"2024","unstructured":"Mohamed SMA, Schofield P, McCalmont H, Moles E, Friedrich KH, Kavallaris M, et al. An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia. Int J Biol Macromol. 2024;254(Pt 1): 127596.","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"775_CR46","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1007\/s00277-023-05456-3","volume":"102","author":"O Candan","year":"2023","unstructured":"Candan O, Demirtas D, Yanik AM, Atagunduz I, Toptas T. The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia. Ann Hematol. 2023;102(12):3647\u20138.","journal-title":"Ann Hematol"},{"issue":"1","key":"775_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12098-023-04782-8","volume":"91","author":"S Ganguly","year":"2024","unstructured":"Ganguly S, Sasi A, Pushpam D, Bakhshi S. Philadelphia chromosome positive and Philadelphia-like acute lymphoblastic leukemia in children and adolescents: current management, controversies and emerging concepts. Indian J Pediatr. 2024;91(1):37\u201346.","journal-title":"Indian J Pediatr"},{"issue":"6","key":"775_CR48","first-page":"2452","volume":"13","author":"J Singh","year":"2023","unstructured":"Singh J, Benjamin M, Pandey AK, Kumari S, Ali MS, Palanichamy JK, et al. Prognostic relevance of surface expression of cytokine receptor-like factor 2 in pediatric B-lineage acute lymphoblastic leukemia. Am J Cancer Res. 2023;13(6):2452\u201370.","journal-title":"Am J Cancer Res"},{"issue":"10","key":"775_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30546","volume":"70","author":"GK Leons","year":"2023","unstructured":"Leons GK, Sharma P, Gupta SK, Gupta R, Rani L, Gajendra S, et al. Detection of a novel SNX2 gene breakpoint in the SNX2::ABL1 fusion transcript in Ph-like B-cell acute lymphoblastic leukemia. Pediatr Blood Cancer. 2023;70(10): e30546.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"775_CR50","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000892","volume":"7","author":"C Palmi","year":"2023","unstructured":"Palmi C, Bresolin S, Junk S, Fazio G, Silvestri D, Zaliova M, et al. Definition and prognostic value of Ph-like and IKZF1plus status in children with down syndrome and B-cell precursor acute lymphoblastic leukemia. Hemasphere. 2023;7(6): e892.","journal-title":"Hemasphere."},{"issue":"6","key":"775_CR51","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00277-023-05241-2","volume":"102","author":"R Alghandour","year":"2023","unstructured":"Alghandour R, Sakr DH, Shaaban Y. Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant-review article. Ann Hematol. 2023;102(6):1287\u2013300.","journal-title":"Ann Hematol"},{"issue":"3","key":"775_CR52","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/j.semdp.2023.04.003","volume":"40","author":"K Davis","year":"2023","unstructured":"Davis K, Sheikh T, Aggarwal N. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia. Semin Diagn Pathol. 2023;40(3):202\u201315.","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"775_CR53","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1080\/10428194.2023.2197538","volume":"64","author":"I Aldoss","year":"2023","unstructured":"Aldoss I, Gu Z, Afkhami M, Mokhtari S, Pullarkat V. Ph-like acute lymphoblastic leukemia in adults: understanding pathogenesis, improving outcomes, and future directions for therapy. Leuk Lymphoma. 2023;64(6):1092\u2013101.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"775_CR54","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1182\/hematology.2022000357","volume":"2022","author":"TH Tran","year":"2022","unstructured":"Tran TH, Tasian SK. Clinical screening for Ph-like ALL and the developing role of TKIs. Hematol Am Soc Hematol Educ Progr. 2022;2022(1):594\u2013602.","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"775_CR55","doi-asserted-by":"crossref","unstructured":"Martinez Anaya D, Moreno Lorenzana D, Reyes Leon A, Juarez Figueroa U, Dean M, et al. Characterization of Philadelphia-like pre-B acute lymphoblastic leukemia: experiences in Mexican pediatric patients. Int J Mol Sci. 2022;23(17).","DOI":"10.3390\/ijms23179587"},{"issue":"5","key":"775_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1587","volume":"5","author":"A Linares Ballesteros","year":"2022","unstructured":"Linares Ballesteros A, Yunis LK, Garcia J, Aponte N, Flechas J, Martinez C, et al. Philadelphia-like acute lymphoblastic leukemia: characterization in a pediatric cohort in a referral center in Colombia. Cancer Rep (Hoboken). 2022;5(5): e1587.","journal-title":"Cancer Rep (Hoboken)."},{"key":"775_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-030-78311-2_2","volume":"181","author":"M Afkhami","year":"2021","unstructured":"Afkhami M, Ally F, Pullarkat V, Pillai RK. Genetics and diagnostic approach to lymphoblastic leukemia\/lymphoma. Cancer Treat Res. 2021;181:17\u201343.","journal-title":"Cancer Treat Res"},{"issue":"1","key":"775_CR58","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/ijlh.13698","volume":"44","author":"H Podgornik","year":"2022","unstructured":"Podgornik H, Doplihar Kebe A, Klun J, Rebersek K, Sucurovic S, Skerget M, et al. Recognition of Philadelphia chromosome-like acute lymphoblastic leukemia as part of routine diagnostic work-up. Int J Lab Hematol. 2022;44(1):142\u20139.","journal-title":"Int J Lab Hematol"},{"key":"775_CR59","doi-asserted-by":"crossref","unstructured":"Iacobucci I, Roberts KG. Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia. Genes (Basel). 2021;12(5):687.","DOI":"10.3390\/genes12050687"},{"issue":"8","key":"775_CR60","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/s41409-021-01253-6","volume":"56","author":"H Cho","year":"2021","unstructured":"Cho H, Kim Y, Yoon JH, Lee J, Lee GD, Son J, et al. Non-inferior long-term outcomes of adults with Philadelphia chromosome-like acute lymphoblastic leukemia. Bone Marrow Transplant. 2021;56(8):1953\u201363.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"775_CR61","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.clml.2020.08.011","volume":"21","author":"V Yadav","year":"2021","unstructured":"Yadav V, Ganesan P, Veeramani R, Kumar VD. Philadelphia-like acute lymphoblastic leukemia: a systematic review. Clin Lymphoma Myeloma Leuk. 2021;21(1):e57\u201365.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"9","key":"775_CR62","volume":"12","author":"N Sherali","year":"2020","unstructured":"Sherali N, Hamadneh T, Aftab S, Alfonso M, Tsouklidis N. Integration of next-generation sequencing in diagnosing and minimal residual disease detection in patients with Philadelphia chromosome-like acute lymphoblastic leukemia. Cureus. 2020;12(9): e10696.","journal-title":"Cureus."},{"issue":"20","key":"775_CR63","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood"},{"issue":"7","key":"775_CR64","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia"},{"issue":"5","key":"775_CR65","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/cncr.35051","volume":"130","author":"DG Gupta","year":"2024","unstructured":"Gupta DG, Varma N, Abdulkadir SA, Sreedharanunni S, Sachdeva MUS, Naseem S, et al. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia. Cancer. 2024;130(5):713\u201326.","journal-title":"Cancer"},{"issue":"8","key":"775_CR66","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/cncr.34665","volume":"129","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Sreedharanunni S, et al. Genomic and proteomic characterization of Philadelphia-like B-lineage acute lymphoblastic leukemia: a report of Indian patients. Cancer. 2023;129(8):1217\u201326.","journal-title":"Cancer"},{"issue":"1","key":"775_CR67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41416-023-02294-y","volume":"129","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Sreedharanunni S, Abdulkadir SA, Naseem S, Sachdeva MUS, et al. \u2019Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting. Br J Cancer. 2023;129(1):143\u201352.","journal-title":"Br J Cancer"},{"issue":"27","key":"775_CR68","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1200\/JCO.2014.55.4105","volume":"32","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Pei D, Campana D, Payne-Turner D, Li Y, Cheng C, et al. Outcomes of children with BCR-ABL1-like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease. J Clin Oncol. 2014;32(27):3012\u201320.","journal-title":"J Clin Oncol"},{"issue":"4","key":"775_CR69","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MOH.0000000000000050","volume":"21","author":"S Izraeli","year":"2014","unstructured":"Izraeli S. Beyond Philadelphia: \u201cPh-like\u201d B cell precursor acute lymphoblastic leukemias\u2014diagnostic challenges and therapeutic promises. Curr Opin Hematol. 2014;21(4):289\u201396.","journal-title":"Curr Opin Hematol"},{"key":"775_CR70","doi-asserted-by":"crossref","unstructured":"Sasaki K, Miyawaki K, Semba Y, Kato K, Nogami J, Sugio T, et al. A Fast and Accurate Diagnostic Method for Ph-like ALL Using the Ncounter System. Blood. 2019;134:375.","DOI":"10.1182\/blood-2019-129625"},{"issue":"2","key":"775_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.blre.2016.09.001","volume":"31","author":"Y Ofran","year":"2017","unstructured":"Ofran Y, Izraeli S. BCR-ABL (Ph)-like acute leukemia-Pathogenesis, diagnosis and therapeutic options. Blood Rev. 2017;31(2):11\u20136.","journal-title":"Blood Rev"},{"key":"775_CR72","doi-asserted-by":"crossref","unstructured":"Shiraz P, Payne KJ, Muffly L. The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia. Int J Mol Sci. 2020;21(6):2913.","DOI":"10.3390\/ijms21062193"},{"issue":"8","key":"775_CR73","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00277-021-04574-0","volume":"100","author":"H Virk","year":"2021","unstructured":"Virk H, Rana S, Sharma P, Bose PL, Yadav DD, Sachdeva MUS, et al. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort. Ann Hematol. 2021;100(8):2031\u201341.","journal-title":"Ann Hematol"},{"issue":"5","key":"775_CR74","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMoa0808253","volume":"360","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360(5):470\u201380.","journal-title":"N Engl J Med"},{"key":"775_CR75","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1200\/EDBK_156628","volume":"35","author":"S Chiaretti","year":"2016","unstructured":"Chiaretti S, Gianfelici V, O\u2019Brien SM, Mullighan CG. Advances in the genetics and therapy of acute lymphoblastic leukemia. Am Soc Clin Oncol Educ Book. 2016;35:e314\u201322.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"775_CR76","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/cncr.31848","volume":"125","author":"S Chiaretti","year":"2019","unstructured":"Chiaretti S, Messina M, Foa R. BCR\/ABL1-like acute lymphoblastic leukemia: how to diagnose and treat? Cancer. 2019;125(2):194\u2013204.","journal-title":"Cancer"},{"issue":"1\u20132","key":"775_CR77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1615\/CritRevOncog.v16.i1-2.30","volume":"16","author":"SK Tasian","year":"2011","unstructured":"Tasian SK, Loh ML. Understanding the biology of CRLF2-overexpressing acute lymphoblastic leukemia. Crit Rev Oncog. 2011;16(1\u20132):13\u201324.","journal-title":"Crit Rev Oncog"},{"issue":"4","key":"775_CR78","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41408-020-0308-3","volume":"10","author":"R Sanchez","year":"2020","unstructured":"Sanchez R, Ribera J, Morgades M, Ayala R, Onecha E, Ruiz-Heredia Y, et al. A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics. Blood Cancer J. 2020;10(4):43.","journal-title":"Blood Cancer J"},{"issue":"5","key":"775_CR79","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/gcc.22439","volume":"56","author":"LJ Russell","year":"2017","unstructured":"Russell LJ, Jones L, Enshaei A, Tonin S, Ryan SL, Eswaran J, et al. Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2017;56(5):363\u201372.","journal-title":"Genes Chromosomes Cancer"},{"issue":"7191","key":"775_CR80","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature06866","volume":"453","author":"CG Mullighan","year":"2008","unstructured":"Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008;453(7191):110\u20134.","journal-title":"Nature"},{"issue":"21","key":"775_CR81","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1182\/blood.V124.21.796.796","volume":"124","author":"W Stock","year":"2014","unstructured":"Stock W, Luger SM, Advani AS, Geyer S, Harvey RC, Mullighan CG, et al. Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): early results of US Intergroup Trial C10403. Blood. 2014;124(21):796.","journal-title":"Blood"},{"issue":"5","key":"775_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.28","volume":"6","author":"T Imamura","year":"2016","unstructured":"Imamura T, Kiyokawa N, Kato M, Imai C, Okamoto Y, Yano M, et al. Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan. Blood Cancer J. 2016;6(5): e419.","journal-title":"Blood Cancer J"},{"issue":"4","key":"775_CR83","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/leu.2016.375","volume":"31","author":"SK Tasian","year":"2017","unstructured":"Tasian SK, Hurtz C, Wertheim GB, Bailey NG, Lim MS, Harvey RC, et al. High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL. Leukemia. 2017;31(4):981\u20134.","journal-title":"Leukemia"},{"issue":"7","key":"775_CR84","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1172\/JCI134424","volume":"130","author":"C Hurtz","year":"2020","unstructured":"Hurtz C, Wertheim GB, Loftus JP, Blumenthal D, Lehman A, Li Y, et al. Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL. J Clin Invest. 2020;130(7):3637\u201353.","journal-title":"J Clin Invest"},{"issue":"17","key":"775_CR85","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1182\/blood-2012-03-415448","volume":"120","author":"SL Maude","year":"2012","unstructured":"Maude SL, Tasian SK, Vincent T, Hall JW, Sheen C, Roberts KG, et al. Targeting JAK1\/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood. 2012;120(17):3510\u20138.","journal-title":"Blood"},{"issue":"2","key":"775_CR86","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1182\/blood-2016-05-707653","volume":"129","author":"SK Tasian","year":"2017","unstructured":"Tasian SK, Teachey DT, Li Y, Shen F, Harvey RC, Chen IM, et al. Potent efficacy of combined PI3K\/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood. 2017;129(2):177\u201387.","journal-title":"Blood"},{"issue":"10","key":"775_CR87","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.3324\/haematol.2021.278697","volume":"106","author":"LM Niswander","year":"2021","unstructured":"Niswander LM, Loftus JP, Lainey E, Caye-Eude A, Pondrom M, Hottman DA, et al. Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia. Haematologica. 2021;106(10):2763\u20137.","journal-title":"Haematologica"},{"issue":"6","key":"775_CR88","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.chembiol.2023.05.007","volume":"30","author":"ML Arwood","year":"2023","unstructured":"Arwood ML, Liu Y, Harkins SK, Weinstock DM, Yang L, Stevenson KE, et al. New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation. Cell Chem Biol. 2023;30(6):618-31 e12.","journal-title":"Cell Chem Biol"},{"issue":"2","key":"775_CR89","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1158\/1535-7163.MCT-14-0647","volume":"14","author":"S Suryani","year":"2015","unstructured":"Suryani S, Bracken LS, Harvey RC, Sia KC, Carol H, Chen IM, et al. Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia. Mol Cancer Ther. 2015;14(2):364\u201374.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"775_CR90","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.18632\/oncotarget.2992","volume":"6","author":"BR Beagle","year":"2015","unstructured":"Beagle BR, Nguyen DM, Mallya S, Tang SS, Lu M, Zeng Z, et al. mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells. Oncotarget. 2015;6(4):2088\u2013100.","journal-title":"Oncotarget"},{"issue":"3","key":"775_CR91","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.18632\/oncotarget.2842","volume":"6","author":"MN Hasan","year":"2015","unstructured":"Hasan MN, Queudeville M, Trentin L, Eckhoff SM, Bronzini I, Palmi C, et al. Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model. Oncotarget. 2015;6(3):1382\u201395.","journal-title":"Oncotarget"},{"issue":"22","key":"775_CR92","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1182\/blood-2015-03-635821","volume":"126","author":"N Kucine","year":"2015","unstructured":"Kucine N, Marubayashi S, Bhagwat N, Papalexi E, Koppikar P, Sanchez Martin M, et al. Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias. Blood. 2015;126(22):2479\u201383.","journal-title":"Blood"},{"issue":"1","key":"775_CR93","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1182\/blood.2023023153","volume":"145","author":"TH Tran","year":"2025","unstructured":"Tran TH, Tasian SK. How I treat Philadelphia chromosome-like acute lymphoblastic leukemia in children, adolescents, and young adults. Blood. 2025;145(1):20\u201334.","journal-title":"Blood"},{"issue":"3","key":"775_CR94","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/10428194.2021.1999439","volume":"63","author":"DG Gupta","year":"2022","unstructured":"Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Binota J, et al. PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of BCR-ABL1-like acute lymphoblastic leukaemia in Indian patients. Leuk Lymphoma. 2022;63(3):633\u201343.","journal-title":"Leuk Lymphoma"},{"key":"775_CR95","doi-asserted-by":"crossref","unstructured":"Gupta DG, Varma N, Abdulkadir SA, Puri A, Sachdeva MU, Naseem S, et al. MRD and genetic profiling of Ph-like B-lineage ALL in resource-limited settings. Int J Cancer Care Deliv. 2024.","DOI":"10.53876\/001c.123868"},{"key":"775_CR96","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1016\/S2152-2650(24)00414-2","volume":"24","author":"DG Gupta","year":"2024","unstructured":"Gupta DG, Varma N, Abdulkadir SA, Puri A, Sachdeva MUS, Naseem S, et al. Prognostic gene alterations and MRD positivity in Ph-like B-lineage ALL in resource-limited settings. Clin Lymphoma Myeloma Leuk. 2024;24:S159.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"775_CR97","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1016\/S2152-2650(24)01094-2","volume":"24","author":"DG Gupta","year":"2024","unstructured":"Gupta DG, Varma N, Abdulkadir SA, Puri A, Singh Sachdeva MU, Naseem S, et al. ALL-194 prognostic gene alterations and MRD positivity in Ph-like B-lineage ALL in resource-limited settings. Clin Lymphoma Myeloma Leuk. 2024;24:S262\u20133.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"20","key":"775_CR98","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1158\/1078-0432.CCR-04-2165","volume":"11","author":"S Chiaretti","year":"2005","unstructured":"Chiaretti S, Li X, Gentleman R, Vitale A, Wang KS, Mandelli F, et al. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation. Clin Cancer Res. 2005;11(20):7209\u201319.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"775_CR99","first-page":"3118","volume":"8","author":"PJ Moos","year":"2002","unstructured":"Moos PJ, Raetz EA, Carlson MA, Szabo A, Smith FE, Willman C, et al. Identification of gene expression profiles that segregate patients with childhood leukemia. Clin Cancer Res. 2002;8(10):3118\u201330.","journal-title":"Clin Cancer Res"},{"key":"775_CR100","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.leukres.2015.11.018","volume":"41","author":"S Chiaretti","year":"2016","unstructured":"Chiaretti S, Brugnoletti F, Messina M, Paoloni F, Fedullo AL, Piciocchi A, et al. CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities. Leuk Res. 2016;41:36\u201342.","journal-title":"Leuk Res"},{"issue":"10","key":"775_CR101","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1080\/10428194.2021.1929964","volume":"63","author":"P Sharma","year":"2022","unstructured":"Sharma P, Rana S, Virk H, Sachdeva MUS, Sharma P, Varma N, et al. The frequency, hematological characteristics, and end-of induction residual disease in B-acute lymphoblastic leukemia with BCR-ABL1-like chimeric gene fusions in a high-risk cohort from India. Leuk Lymphoma. 2022;63(10):2474\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"19","key":"775_CR102","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1182\/blood-2017-06-743252","volume":"130","author":"SK Tasian","year":"2017","unstructured":"Tasian SK, Loh ML, Hunger SP. Philadelphia chromosome-like acute lymphoblastic leukemia. Blood. 2017;130(19):2064\u201372.","journal-title":"Blood"},{"issue":"6","key":"775_CR103","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1111\/bjh.19771","volume":"205","author":"K Ashouri","year":"2024","unstructured":"Ashouri K, Hom B, Ginosyan AA, Rahimi Y, Resnick K, Nittur V, et al. Philadelphia-like B-cell acute lymphoblastic leukaemia: disease features and outcomes in the era of immunotherapy. Br J Haematol. 2024;205(6):2234\u201347.","journal-title":"Br J Haematol"},{"issue":"9","key":"775_CR104","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","volume":"35","author":"I Iacobucci","year":"2017","unstructured":"Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol. 2017;35(9):975\u201383.","journal-title":"J Clin Oncol"},{"issue":"26","key":"775_CR105","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","volume":"115","author":"RC Harvey","year":"2010","unstructured":"Harvey RC, Mullighan CG, Chen IM, Wharton W, Mikhail FM, Carroll AJ, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 2010;115(26):5312\u201321.","journal-title":"Blood"},{"issue":"3","key":"775_CR106","first-page":"100","volume":"48","author":"W Su","year":"2022","unstructured":"Su W, Zhao A, Nahoul J, Mendelsohn H, Hamid B, Tirado CA. CRLF2 gene in B-cell acute lymphoblastic leukemia. J Assoc Genet Technol. 2022;48(3):100\u20135.","journal-title":"J Assoc Genet Technol."},{"issue":"1\u20132","key":"775_CR107","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000056941","volume":"93","author":"Y Tonozuka","year":"2001","unstructured":"Tonozuka Y, Fujio K, Sugiyama T, Nosaka T, Hirai M, Kitamura T. Molecular cloning of a human novel type I cytokine receptor related to delta1\/TSLPR. Cytogenet Cell Genet. 2001;93(1\u20132):23\u20135.","journal-title":"Cytogenet Cell Genet"},{"issue":"2","key":"775_CR108","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4049\/jimmunol.162.2.677","volume":"162","author":"SD Levin","year":"1999","unstructured":"Levin SD, Koelling RM, Friend SL, Isaksen DE, Ziegler SF, Perlmutter RM, et al. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J Immunol. 1999;162(2):677\u201383.","journal-title":"J Immunol"},{"issue":"1","key":"775_CR109","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/76923","volume":"1","author":"A Pandey","year":"2000","unstructured":"Pandey A, Ozaki K, Baumann H, Levin SD, Puel A, Farr AG, et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol. 2000;1(1):59\u201364.","journal-title":"Nat Immunol"},{"issue":"5","key":"775_CR110","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1084\/jem.192.5.659","volume":"192","author":"LS Park","year":"2000","unstructured":"Park LS, Martin U, Garka K, Gliniak B, Di Santo JP, Muller W, et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med. 2000;192(5):659\u201370.","journal-title":"J Exp Med"},{"issue":"11","key":"775_CR111","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.4049\/jimmunol.163.11.5971","volume":"163","author":"DE Isaksen","year":"1999","unstructured":"Isaksen DE, Baumann H, Trobridge PA, Farr AG, Levin SD, Ziegler SF. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol. 1999;163(11):5971\u20137.","journal-title":"J Immunol"},{"issue":"2\u20133","key":"775_CR112","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1515\/bc.2010.029","volume":"391","author":"A Wohlmann","year":"2010","unstructured":"Wohlmann A, Sebastian K, Borowski A, Krause S, Friedrich K. Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function. Biol Chem. 2010;391(2\u20133):181\u20136.","journal-title":"Biol Chem"},{"issue":"4","key":"775_CR113","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","volume":"120","author":"SK Tasian","year":"2012","unstructured":"Tasian SK, Doral MY, Borowitz MJ, Wood BL, Chen IM, Harvey RC, et al. Aberrant STAT5 and PI3K\/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia. Blood. 2012;120(4):833\u201342.","journal-title":"Blood"},{"issue":"18","key":"775_CR114","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1002\/cncr.30129","volume":"122","author":"BM Giddings","year":"2016","unstructured":"Giddings BM, Whitehead TP, Metayer C, Miller MD. Childhood leukemia incidence in California: high and rising in the Hispanic population. Cancer. 2016;122(18):2867\u201375.","journal-title":"Cancer"},{"issue":"26","key":"775_CR115","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","volume":"115","author":"G Cario","year":"2010","unstructured":"Cario G, Zimmermann M, Romey R, Gesk S, Vater I, Harbott J, et al. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. Blood. 2010;115(26):5393\u20137.","journal-title":"Blood"},{"issue":"15","key":"775_CR116","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1182\/blood-2011-11-394221","volume":"119","author":"IM Chen","year":"2012","unstructured":"Chen IM, Harvey RC, Mullighan CG, Gastier-Foster J, Wharton W, Kang H, et al. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children\u2019s Oncology Group study. Blood. 2012;119(15):3512\u201322.","journal-title":"Blood"},{"issue":"3","key":"775_CR117","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/cam4.87","volume":"2","author":"D Asai","year":"2013","unstructured":"Asai D, Imamura T, Suenobu S, Saito A, Hasegawa D, Deguchi T, et al. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan. Cancer Med. 2013;2(3):412\u20139.","journal-title":"Cancer Med"},{"issue":"10","key":"775_CR118","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1038\/leu.2012.101","volume":"26","author":"C Palmi","year":"2012","unstructured":"Palmi C, Vendramini E, Silvestri D, Longinotti G, Frison D, Cario G, et al. Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia. Leukemia. 2012;26(10):2245\u201353.","journal-title":"Leukemia"},{"issue":"9","key":"775_CR119","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41408-021-00538-9","volume":"11","author":"ZH Abdel-Rahman","year":"2021","unstructured":"Abdel-Rahman ZH, Heckman MG, Anagnostou T, White LJ, Kloft-Nelson SM, Knudson RA, et al. Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes. Blood Cancer J. 2021;11(9):156.","journal-title":"Blood Cancer J"},{"issue":"6","key":"775_CR120","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4331\/wjbc.v2.i6.132","volume":"2","author":"M Sellars","year":"2011","unstructured":"Sellars M, Kastner P, Chan S. Ikaros in B cell development and function. World J Biol Chem. 2011;2(6):132\u20139.","journal-title":"World J Biol Chem"},{"issue":"1","key":"775_CR121","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0092-8674(94)90407-3","volume":"79","author":"K Georgopoulos","year":"1994","unstructured":"Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 1994;79(1):143\u201356.","journal-title":"Cell"},{"issue":"15","key":"775_CR122","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","volume":"122","author":"A van der Veer","year":"2013","unstructured":"van der Veer A, Waanders E, Pieters R, Willemse ME, Van Reijmersdal SV, Russell LJ, et al. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. Blood. 2013;122(15):2622\u20139.","journal-title":"Blood"},{"issue":"4","key":"775_CR123","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MOH.0000000000000352","volume":"24","author":"Y Hu","year":"2017","unstructured":"Hu Y, Yoshida T, Georgopoulos K. Transcriptional circuits in B cell transformation. Curr Opin Hematol. 2017;24(4):345\u201352.","journal-title":"Curr Opin Hematol"},{"issue":"15","key":"775_CR124","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1182\/blood-2015-06-651505","volume":"126","author":"C Song","year":"2015","unstructured":"Song C, Gowda C, Pan X, Ding Y, Tong Y, Tan BH, et al. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Blood. 2015;126(15):1813\u201322.","journal-title":"Blood"},{"issue":"10","key":"775_CR125","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood-2008-08-173963","volume":"114","author":"I Iacobucci","year":"2009","unstructured":"Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, et al. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell\u2019Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood. 2009;114(10):2159\u201367.","journal-title":"Blood"},{"issue":"7","key":"775_CR126","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/leu.2010.87","volume":"24","author":"RP Kuiper","year":"2010","unstructured":"Kuiper RP, Waanders E, van der Velden VH, van Reijmersdal SV, Venkatachalam R, Scheijen B, et al. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia. 2010;24(7):1258\u201364.","journal-title":"Leukemia"},{"issue":"7","key":"775_CR127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040934","volume":"7","author":"I Iacobucci","year":"2012","unstructured":"Iacobucci I, Iraci N, Messina M, Lonetti A, Chiaretti S, Valli E, et al. IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia. PLoS ONE. 2012;7(7): e40934.","journal-title":"PLoS ONE"},{"issue":"10","key":"775_CR128","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/pbc.24571","volume":"60","author":"Y Yamashita","year":"2013","unstructured":"Yamashita Y, Shimada A, Yamada T, Yamaji K, Hori T, Tsurusawa M, et al. IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(10):1587\u201392.","journal-title":"Pediatr Blood Cancer"},{"issue":"31","key":"775_CR129","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","volume":"27","author":"G Martinelli","year":"2009","unstructured":"Martinelli G, Iacobucci I, Storlazzi CT, Vignetti M, Paoloni F, Cilloni D, et al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol. 2009;27(31):5202\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"775_CR130","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3324\/haematol.2012.073965","volume":"98","author":"A Caye","year":"2013","unstructured":"Caye A, Beldjord K, Mass-Malo K, Drunat S, Soulier J, Gandemer V, et al. Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia. Haematologica. 2013;98(4):597\u2013601.","journal-title":"Haematologica"},{"issue":"2","key":"775_CR131","first-page":"126","volume":"54","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang L, Zou Y, Chang L, Wei W, Ruan M, et al. Significance of ikaros family zinc finger 1 deletion in pediatric B-acute lymphoblastic leukemia without reproducible cytogenetic abnormalities. Zhonghua Er Ke Za Zhi. 2016;54(2):126\u201330.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"2","key":"775_CR132","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1111\/ijlh.12945","volume":"41","author":"J Hashiguchi","year":"2019","unstructured":"Hashiguchi J, Onozawa M, Okada K, Amano T, Hatanaka KC, Nishihara H, et al. Quantitative detection of IKZF1 deletion by digital PCR in patients with acute lymphoblastic leukemia. Int J Lab Hematol. 2019;41(2):e38\u201340.","journal-title":"Int J Lab Hematol"},{"issue":"21","key":"775_CR133","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1182\/blood.V122.21.826.826","volume":"122","author":"RC Harvey","year":"2013","unstructured":"Harvey RC, Kang H, Roberts KG, Chen I-ML, Atlas SR, Bedrick EJ, et al. Development and validation of a highly sensitive and specific gene expression classifier to prospectively screen and identify B-precursor acute lymphoblastic leukemia (ALL) patients with a philadelphia chromosome-like (\u201cPh-like\u201d or \u201cBCR-ABL1-Like\u201d) signature for therapeutic targeting and clinical intervention. Blood. 2013;122(21):826.","journal-title":"Blood"},{"issue":"6","key":"775_CR134","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1080\/10428194.2022.2025797","volume":"63","author":"B Kaumeyer","year":"2022","unstructured":"Kaumeyer B, Fidai S, Sukhanova M, Yap KL, Segal J, Raca G, et al. MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia. Leuk Lymphoma. 2022;63(6):1436\u201344.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"775_CR135","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12288-018-0997-y","volume":"34","author":"S Totadri","year":"2018","unstructured":"Totadri S, Singh M, Trehan A, Varma N, Bhatia P. Keeping PACE with Ph positive to Ph-like detection in B-lineage acute lymphoblastic leukemia: a practical and cost effective (PACE) approach in a resource constrained setting. Indian J Hematol Blood Transfus. 2018;34(4):595\u2013601.","journal-title":"Indian J Hematol Blood Transfus."},{"issue":"5","key":"775_CR136","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41408-020-0313-6","volume":"10","author":"N Patkar","year":"2020","unstructured":"Patkar N, Bhanshe P, Rajpal S, Joshi S, Chaudhary S, Chatterjee G, et al. NARASIMHA: novel assay based on targeted RNA sequencing to identify ChiMeric gene fusions in hematological malignancies. Blood Cancer J. 2020;10(5):50.","journal-title":"Blood Cancer J"},{"issue":"1","key":"775_CR137","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/16078454.2022.2052602","volume":"27","author":"WF Silva","year":"2022","unstructured":"Silva WF, Amano MT, Perruso LL, Cordeiro MG, Kishimoto RK, de Medeiros LA, et al. Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation. Hematology. 2022;27(1):396\u2013403.","journal-title":"Hematology"},{"issue":"6","key":"775_CR138","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/jha2.1030","volume":"5","author":"K Lima","year":"2024","unstructured":"Lima K, Rojas CAO, Nogueira FL, da Silva WF, Cavaglieri RC, Nardinelli L, et al. Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients. EJHaem. 2024;5(6):1366\u20139.","journal-title":"EJHaem."},{"key":"775_CR139","unstructured":"https:\/\/pgimerdikshatguptaneelamvarmaashishkumar.shinyapps.io\/PGIMER_PHi-RACE\/."},{"issue":"8","key":"775_CR140","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1007\/s10238-023-01131-z","volume":"23","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Abdulkadir SA, Singh P, Sachdeva MUS, Naseem S, et al. Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia. Clin Exp Med. 2023;23(8):4539\u201351.","journal-title":"Clin Exp Med"},{"issue":"6","key":"775_CR141","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1007\/s11033-022-07337-w","volume":"49","author":"DG Gupta","year":"2022","unstructured":"Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Bose P, et al. Identification and validation of suitable housekeeping genes for gene expression studies in BCR-ABL1 positive B-lineage acute lymphoblastic leukemia. Mol Biol Rep. 2022;49(6):4841\u20138.","journal-title":"Mol Biol Rep"},{"key":"775_CR142","unstructured":"Lin DN, Li QL, He XJ, Li H, Liao LB, He H, et al. [Diagnosis of adult Philadelphia chromosome-like acute lymphoblastic leukemia by fluorescence in situ hybridization]. Zhonghua Xue Ye Xue Za Zhi. 2020;41(9):749\u201355."},{"key":"775_CR143","doi-asserted-by":"crossref","unstructured":"Mi JQ, Wang X, Yao Y, Lu HJ, Jiang XX, Zhou JF, et al. Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases. Leukemia. 2012;26(7):1507\u201316.","DOI":"10.1038\/leu.2012.23"},{"key":"775_CR144","unstructured":"Cao PX, Zhang GS, Wang F, Chen X, Zhang Y, Wang MY, et al. [Transcriptome sequencing-based classification and quantification of IKZF1 transcript isoforms in B-cell acute lymphoblastic leukemia]. Zhonghua Yi Xue Za Zhi. 2021;101(13):926\u201333."}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-025-00775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-025-00775-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-025-00775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T20:02:17Z","timestamp":1746734537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-025-00775-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1007\/s40291-025-00775-9","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"17 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dikshat Gopal Gupta, Monika, and Neelam Varma declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"DGG, M, NV performed the literature search, reviewed, drafted the manuscript, and endorsed the final version. All authors have given their approval to the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}